Amgen
AMGN
1,892 hedge funds and large institutions have $95.2B invested in Amgen in 2018 Q4 according to their latest regulatory filings, with 213 funds opening new positions, 684 increasing their positions, 715 reducing their positions, and 100 closing their positions.
113% more first-time investments, than exits
New positions opened: 213 | Existing positions closed: 100
28% more funds holding in top 10
Funds holding in top 10: 105 → 134 (+29)
5% more funds holding
Funds holding: 1,797 → 1,892 (+95)
0.35% more ownership
Funds ownership: 77.25% → 77.6% (+0.35%)
4% less repeat investments, than reductions
Existing positions increased: 684 | Existing positions reduced: 715
8% less capital invested
Capital invested by funds: $104B → $95.2B (-$8.39B)
29% less call options, than puts
Call options by funds: $912M | Put options by funds: $1.28B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$198M |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$182M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$178M |
| 4 |
BlackRock
New York
|
+$177M |
| 5 |
Morgan Stanley
New York
|
+$149M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$647M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$528M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$392M |
| 4 |
Primecap Management
Pasadena,
California
|
-$185M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$178M |
AMGN Hedge Fund Activity: Q4 2018 in Review
1,892 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2018, worth a combined $95.2B — down 8.1% from $104B a quarter earlier.
Buyers outnumbered sellers: 213 funds opened new AMGN positions and 100 closed out — a net gain of 113 holders — while 684 added to existing stakes and 715 trimmed.
The largest buyer was Vanguard Group, adding an estimated $198M. The largest seller was Capital World Investors, cutting an estimated $647M.
- 1,892 institutional investors held Amgen (AMGN) as of Q4 2018, up from 1,797 in Q3 2018.
- Funds reported $95.2B of Amgen stock for Q4 2018, down 8.1% quarter-over-quarter.
- 213 funds opened new Amgen positions in Q4 2018 and 100 closed out, a net change of +113 holders.
- The largest Amgen buyer in Q4 2018 was Vanguard Group, an estimated $198M added.
- The largest Amgen seller in Q4 2018 was Capital World Investors, an estimated $647M sold.
Based on aggregated 13F filings for Q4 2018.